Ovid Therapeutics (OVID) Earnings Date & Reports

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

OVID is expected to report earnings to rise 10.23% to -14 cents per share on May 08

Ovid Therapeutics OVID Stock Earnings Reports

Q1'25

Est.

$-0.14

Q4'24

Beat

by $0.04

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.34

Q1'24

Beat

by $0.05

The last earnings report on March 11 showed earnings per share of -12 cents, beating the estimate of -17 cents. With 759.81K shares outstanding, the current market capitalization sits at 23.94M.

View a ticker or compare two or three

Compare

OVID